492 filings
Page 4 of 25
4
e08n6u9juy
17 Mar 20
Revance Therapeutics / Abhay Joshi ownership change
8:34pm
SC 13G
5zfq5w g30
13 Mar 20
Revance Therapeutics / GIC Private ownership change
4:22pm
SEC STAFF
6d2 0ibkf
27 Feb 20
SEC staff action: Order
12:00am
8-K
ry4a6g337q rjmx1n8
24 Feb 20
Revance Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update
4:08pm
4/A
lhr6gbo3ca 8mtr
19 Feb 20
Revance Therapeutics / Mark J Foley ownership change
8:25pm
4
uk86p8m xg8eu
19 Feb 20
Revance Therapeutics / Caryn Gordon McDowell ownership change
8:23pm
4
r9uk5i1d 5w
19 Feb 20
Revance Therapeutics / Abhay Joshi ownership change
8:22pm
4
qie14 wbx78mjn0rp
19 Feb 20
Revance Therapeutics / Tobin Schilke ownership change
8:21pm
4
yyjk298nusojo6
19 Feb 20
Revance Therapeutics / Dustin S Sjuts ownership change
8:20pm
4
td82nsr92 21e0ci
19 Feb 20
Revance Therapeutics / Dwight Moxie ownership change
8:18pm
3
asdcj0vjc2tk8f
19 Feb 20
Revance Therapeutics / Dwight Moxie ownership change
8:17pm
8-K
rasmu60b l6lc
14 Feb 20
Entry into a Material Definitive Agreement
5:04pm
SC 13G/A
cbbam
14 Feb 20
Revance Therapeutics, Inc.
12:00am
8-K
c30 ztxclbz1
10 Feb 20
Revance Announces Proposed Private Offering of
4:01pm
8-K
3mq6nmen t7
7 Feb 20
Departure of Directors or Certain Officers
4:12pm
SEC STAFF
b7iebh2x634usnp1r60s
7 Feb 20
SEC staff action: Order
12:00am
SC 13G/A
l0sciy
6 Feb 20
Beneficial ownership report (amended)
9:10am
SC 13G/A
3kf6bz
5 Feb 20
Beneficial ownership report (amended)
3:17pm
CT ORDER
u4oeis 8g4f4s5s
3 Feb 20
Confidential treatment order
2:20pm